Avalyn Pharmaceuticals

Avalyn Pharmaceuticals

MA - Cambridge
Pharmaceutical
WebsiteLinkedInCareers Page

Focus: Therapies for the treatment of Idiopathic Pulmonary Fibrosis

Avalyn Pharmaceuticals is a life sciences company focused on Therapies for the treatment of Idiopathic Pulmonary Fibrosis.

RespiratoryNeurology
Funding Stage
PUBLIC
Employees
1-50
Total Funding
$150M
Open Jobs
2

Pipeline & Clinical Trials

Phase 2
Clinical Trials (1)
NCT07194382AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Phase 2
Phase 2
Clinical Trials (1)
NCT06329401A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Phase 2
Phase 2
Clinical Trials (1)
NCT06951217An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Phase 2

Open Jobs (2)

Senior Manager / Associate Director, Regulatory Affairs

Remote
Regulatory Affairs
2w ago
From $163K/yr

Director, Biostatistics

Remote
Clinical Operations
1mo ago
From $228K/yr
Interview Prep Quick Facts
Portfolio: 3 clinical trials
Open Roles: 2 active jobs

Hiring Trend

Stable
2
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles